Goldman Sachs’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,527,724
Closed -$179M 6651
2022
Q3
$179M Sell
6,527,724
-127,492
-2% -$3.16M 0.05% 428
2022
Q2
$153M Buy
6,655,216
+4,732,208
+246% +$111M 0.04% 494
2022
Q1
$41.9M Sell
1,923,008
-2,382,651
-55% -$49.5M 0.01% 1429
2021
Q4
$92.1M Sell
4,305,659
-755,416
-15% -$15.8M 0.02% 862
2021
Q3
$106M Sell
5,061,075
-125,124
-2% -$2.73M 0.02% 721
2021
Q2
$119M Buy
5,186,199
+1,842,558
+55% +$42.4M 0.03% 624
2021
Q1
$73.9M Buy
3,343,641
+212,123
+7% +$4.91M 0.02% 860
2020
Q4
$58.4M Buy
3,131,518
+1,365,349
+77% +$22.4M 0.02% 1004
2020
Q3
$25.6M Sell
1,766,169
-182,058
-9% -$2.31M 0.01% 1546
2020
Q2
$21.8M Sell
1,948,227
-856,639
-31% -$9.62M 0.01% 1611
2020
Q1
$28M Buy
2,804,866
+1,970,610
+236% +$27.6M 0.01% 1263
2019
Q4
$13.7M Sell
834,256
-41,879
-5% -$562K ﹤0.01% 2189
2019
Q3
$10.6M Sell
876,135
-40,089
-4% -$551K ﹤0.01% 2283
2019
Q2
$13.4M Buy
+916,224
New +$13.6M ﹤0.01% 2155

Other funds holding CHNG

Goldman Sachs's CHNG Position: Q4 2022 in Review

Goldman Sachs sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 6,527,724 shares — an estimated $179M sold.

Goldman Sachs first reported a position in CHNG in Q2 2019 and held it in 14 quarters. The position peaked at $179M in Q3 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Goldman Sachs reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Goldman Sachs sold 6,527,724 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $179M.
  • Goldman Sachs first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Goldman Sachs's Change Healthcare Inc. Common Stock position peaked at $179M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.